- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Dog Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Dog Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Below 6 Months accounting for % of the Dog Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Attenuated Live Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Dog Vaccines include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, and Eli Lilly, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Dog Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Market segment by Application can be divided into
Below 6 Months
Above Months
The key market players for global Dog Vaccines market are listed below:
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska Co.
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dog Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dog Vaccines, with price, sales, revenue and global market share of Dog Vaccines from 2019 to 2022.
Chapter 3, the Dog Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dog Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Dog Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Dog Vaccines.
Chapter 13, 14, and 15, to describe Dog Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Dog Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dog Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Attenuated Live Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Inactivated Vaccines
1.2.5 Subunit Vaccines
1.2.6 Toxoid Vaccines
1.2.7 DNA Vaccines
1.2.8 Recombinant Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Dog Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Below 6 Months
1.3.3 Above Months
1.4 Global Dog Vaccines Market Size & Forecast
1.4.1 Global Dog Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Dog Vaccines Sales in Volume (2017-2028)
1.4.3 Global Dog Vaccines Price (2017-2028)
1.5 Global Dog Vaccines Production Capacity Analysis
1.5.1 Global Dog Vaccines Total Production Capacity (2017-2028)
1.5.2 Global Dog Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Dog Vaccines Market Drivers
1.6.2 Dog Vaccines Market Restraints
1.6.3 Dog Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Bayer Healthcare
2.1.1 Bayer Healthcare Details
2.1.2 Bayer Healthcare Major Business
2.1.3 Bayer Healthcare Dog Vaccines Product and Services
2.1.4 Bayer Healthcare Dog Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Vetoquinol S.A
2.2.1 Vetoquinol S.A Details
2.2.2 Vetoquinol S.A Major Business
2.2.3 Vetoquinol S.A Dog Vaccines Product and Services
2.2.4 Vetoquinol S.A Dog Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Dog Vaccines Product and Services
2.3.4 Boehringer Ingelheim Dog Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Ceva
2.4.1 Ceva Details
2.4.2 Ceva Major Business
2.4.3 Ceva Dog Vaccines Product and Services
2.4.4 Ceva Dog Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business
2.5.3 Eli Lilly Dog Vaccines Product and Services
2.5.4 Eli Lilly Dog Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Heska Co.
2.6.1 Heska Co. Details
2.6.2 Heska Co. Major Business
2.6.3 Heska Co. Dog Vaccines Product and Services
2.6.4 Heska Co. Dog Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Merck Animal Health
2.7.1 Merck Animal Health Details
2.7.2 Merck Animal Health Major Business
2.7.3 Merck Animal Health Dog Vaccines Product and Services
2.7.4 Merck Animal Health Dog Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Merial (Sanofi)
2.8.1 Merial (Sanofi) Details
2.8.2 Merial (Sanofi) Major Business
2.8.3 Merial (Sanofi) Dog Vaccines Product and Services
2.8.4 Merial (Sanofi) Dog Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Virbac
2.9.1 Virbac Details
2.9.2 Virbac Major Business
2.9.3 Virbac Dog Vaccines Product and Services
2.9.4 Virbac Dog Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Zoetis (Pfizer)
2.10.1 Zoetis (Pfizer) Details
2.10.2 Zoetis (Pfizer) Major Business
2.10.3 Zoetis (Pfizer) Dog Vaccines Product and Services
2.10.4 Zoetis (Pfizer) Dog Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Dog Vaccines Breakdown Data by Manufacturer
3.1 Global Dog Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Dog Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Dog Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Dog Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 Dog Vaccines Manufacturer Market Share in 2021
3.5 Global Dog Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Dog Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Dog Vaccines Market Size by Region
4.1.1 Global Dog Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global Dog Vaccines Revenue by Region (2017-2028)
4.2 North America Dog Vaccines Revenue (2017-2028)
4.3 Europe Dog Vaccines Revenue (2017-2028)
4.4 Asia-Pacific Dog Vaccines Revenue (2017-2028)
4.5 South America Dog Vaccines Revenue (2017-2028)
4.6 Middle East and Africa Dog Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Dog Vaccines Sales in Volume by Type (2017-2028)
5.2 Global Dog Vaccines Revenue by Type (2017-2028)
5.3 Global Dog Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Dog Vaccines Sales in Volume by Application (2017-2028)
6.2 Global Dog Vaccines Revenue by Application (2017-2028)
6.3 Global Dog Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Dog Vaccines Sales by Type (2017-2028)
7.2 North America Dog Vaccines Sales by Application (2017-2028)
7.3 North America Dog Vaccines Market Size by Country
7.3.1 North America Dog Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America Dog Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Dog Vaccines Sales by Type (2017-2028)
8.2 Europe Dog Vaccines Sales by Application (2017-2028)
8.3 Europe Dog Vaccines Market Size by Country
8.3.1 Europe Dog Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe Dog Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Dog Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific Dog Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific Dog Vaccines Market Size by Region
9.3.1 Asia-Pacific Dog Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Dog Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Dog Vaccines Sales by Type (2017-2028)
10.2 South America Dog Vaccines Sales by Application (2017-2028)
10.3 South America Dog Vaccines Market Size by Country
10.3.1 South America Dog Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America Dog Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Dog Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa Dog Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa Dog Vaccines Market Size by Country
11.3.1 Middle East & Africa Dog Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Dog Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Dog Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Dog Vaccines
12.3 Dog Vaccines Production Process
12.4 Dog Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Dog Vaccines Typical Distributors
13.3 Dog Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Dog Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Dog Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bayer Healthcare Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Healthcare Major Business
Table 5. Bayer Healthcare Dog Vaccines Product and Services
Table 6. Bayer Healthcare Dog Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Vetoquinol S.A Basic Information, Manufacturing Base and Competitors
Table 8. Vetoquinol S.A Major Business
Table 9. Vetoquinol S.A Dog Vaccines Product and Services
Table 10. Vetoquinol S.A Dog Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 12. Boehringer Ingelheim Major Business
Table 13. Boehringer Ingelheim Dog Vaccines Product and Services
Table 14. Boehringer Ingelheim Dog Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Ceva Basic Information, Manufacturing Base and Competitors
Table 16. Ceva Major Business
Table 17. Ceva Dog Vaccines Product and Services
Table 18. Ceva Dog Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 20. Eli Lilly Major Business
Table 21. Eli Lilly Dog Vaccines Product and Services
Table 22. Eli Lilly Dog Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Heska Co. Basic Information, Manufacturing Base and Competitors
Table 24. Heska Co. Major Business
Table 25. Heska Co. Dog Vaccines Product and Services
Table 26. Heska Co. Dog Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 28. Merck Animal Health Major Business
Table 29. Merck Animal Health Dog Vaccines Product and Services
Table 30. Merck Animal Health Dog Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Merial (Sanofi) Basic Information, Manufacturing Base and Competitors
Table 32. Merial (Sanofi) Major Business
Table 33. Merial (Sanofi) Dog Vaccines Product and Services
Table 34. Merial (Sanofi) Dog Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Virbac Basic Information, Manufacturing Base and Competitors
Table 36. Virbac Major Business
Table 37. Virbac Dog Vaccines Product and Services
Table 38. Virbac Dog Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Zoetis (Pfizer) Basic Information, Manufacturing Base and Competitors
Table 40. Zoetis (Pfizer) Major Business
Table 41. Zoetis (Pfizer) Dog Vaccines Product and Services
Table 42. Zoetis (Pfizer) Dog Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Dog Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Doses)
Table 44. Global Dog Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Dog Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Dog Vaccines Production Capacity by Company, (K Doses): 2020 VS 2021
Table 47. Head Office and Dog Vaccines Production Site of Key Manufacturer
Table 48. Dog Vaccines New Entrant and Capacity Expansion Plans
Table 49. Dog Vaccines Mergers & Acquisitions in the Past Five Years
Table 50. Global Dog Vaccines Sales by Region (2017-2022) & (K Doses)
Table 51. Global Dog Vaccines Sales by Region (2023-2028) & (K Doses)
Table 52. Global Dog Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Dog Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Dog Vaccines Sales by Type (2017-2022) & (K Doses)
Table 55. Global Dog Vaccines Sales by Type (2023-2028) & (K Doses)
Table 56. Global Dog Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Dog Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Dog Vaccines Price by Type (2017-2022) & (USD/Dose)
Table 59. Global Dog Vaccines Price by Type (2023-2028) & (USD/Dose)
Table 60. Global Dog Vaccines Sales by Application (2017-2022) & (K Doses)
Table 61. Global Dog Vaccines Sales by Application (2023-2028) & (K Doses)
Table 62. Global Dog Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Dog Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Dog Vaccines Price by Application (2017-2022) & (USD/Dose)
Table 65. Global Dog Vaccines Price by Application (2023-2028) & (USD/Dose)
Table 66. North America Dog Vaccines Sales by Country (2017-2022) & (K Doses)
Table 67. North America Dog Vaccines Sales by Country (2023-2028) & (K Doses)
Table 68. North America Dog Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Dog Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Dog Vaccines Sales by Type (2017-2022) & (K Doses)
Table 71. North America Dog Vaccines Sales by Type (2023-2028) & (K Doses)
Table 72. North America Dog Vaccines Sales by Application (2017-2022) & (K Doses)
Table 73. North America Dog Vaccines Sales by Application (2023-2028) & (K Doses)
Table 74. Europe Dog Vaccines Sales by Country (2017-2022) & (K Doses)
Table 75. Europe Dog Vaccines Sales by Country (2023-2028) & (K Doses)
Table 76. Europe Dog Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Dog Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Dog Vaccines Sales by Type (2017-2022) & (K Doses)
Table 79. Europe Dog Vaccines Sales by Type (2023-2028) & (K Doses)
Table 80. Europe Dog Vaccines Sales by Application (2017-2022) & (K Doses)
Table 81. Europe Dog Vaccines Sales by Application (2023-2028) & (K Doses)
Table 82. Asia-Pacific Dog Vaccines Sales by Region (2017-2022) & (K Doses)
Table 83. Asia-Pacific Dog Vaccines Sales by Region (2023-2028) & (K Doses)
Table 84. Asia-Pacific Dog Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Dog Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Dog Vaccines Sales by Type (2017-2022) & (K Doses)
Table 87. Asia-Pacific Dog Vaccines Sales by Type (2023-2028) & (K Doses)
Table 88. Asia-Pacific Dog Vaccines Sales by Application (2017-2022) & (K Doses)
Table 89. Asia-Pacific Dog Vaccines Sales by Application (2023-2028) & (K Doses)
Table 90. South America Dog Vaccines Sales by Country (2017-2022) & (K Doses)
Table 91. South America Dog Vaccines Sales by Country (2023-2028) & (K Doses)
Table 92. South America Dog Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Dog Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Dog Vaccines Sales by Type (2017-2022) & (K Doses)
Table 95. South America Dog Vaccines Sales by Type (2023-2028) & (K Doses)
Table 96. South America Dog Vaccines Sales by Application (2017-2022) & (K Doses)
Table 97. South America Dog Vaccines Sales by Application (2023-2028) & (K Doses)
Table 98. Middle East & Africa Dog Vaccines Sales by Region (2017-2022) & (K Doses)
Table 99. Middle East & Africa Dog Vaccines Sales by Region (2023-2028) & (K Doses)
Table 100. Middle East & Africa Dog Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Dog Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Dog Vaccines Sales by Type (2017-2022) & (K Doses)
Table 103. Middle East & Africa Dog Vaccines Sales by Type (2023-2028) & (K Doses)
Table 104. Middle East & Africa Dog Vaccines Sales by Application (2017-2022) & (K Doses)
Table 105. Middle East & Africa Dog Vaccines Sales by Application (2023-2028) & (K Doses)
Table 106. Dog Vaccines Raw Material
Table 107. Key Manufacturers of Dog Vaccines Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Dog Vaccines Typical Distributors
Table 111. Dog Vaccines Typical Customers
List of Figures
Figure 1. Dog Vaccines Picture
Figure 2. Global Dog Vaccines Revenue Market Share by Type in 2021
Figure 3. Attenuated Live Vaccines
Figure 4. Conjugate Vaccines
Figure 5. Inactivated Vaccines
Figure 6. Subunit Vaccines
Figure 7. Toxoid Vaccines
Figure 8. DNA Vaccines
Figure 9. Recombinant Vaccines
Figure 10. Global Dog Vaccines Revenue Market Share by Application in 2021
Figure 11. Below 6 Months
Figure 12. Above Months
Figure 13. Global Dog Vaccines Revenue, (USD Million) & (K Doses): 2017 & 2021 & 2028
Figure 14. Global Dog Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Dog Vaccines Sales (2017-2028) & (K Doses)
Figure 16. Global Dog Vaccines Price (2017-2028) & (USD/Dose)
Figure 17. Global Dog Vaccines Production Capacity (2017-2028) & (K Doses)
Figure 18. Global Dog Vaccines Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Dog Vaccines Market Drivers
Figure 20. Dog Vaccines Market Restraints
Figure 21. Dog Vaccines Market Trends
Figure 22. Global Dog Vaccines Sales Market Share by Manufacturer in 2021
Figure 23. Global Dog Vaccines Revenue Market Share by Manufacturer in 2021
Figure 24. Dog Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Dog Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Dog Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Dog Vaccines Sales Market Share by Region (2017-2028)
Figure 28. Global Dog Vaccines Revenue Market Share by Region (2017-2028)
Figure 29. North America Dog Vaccines Revenue (2017-2028) & (USD Million)
Figure 30. Europe Dog Vaccines Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Dog Vaccines Revenue (2017-2028) & (USD Million)
Figure 32. South America Dog Vaccines Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Dog Vaccines Revenue (2017-2028) & (USD Million)
Figure 34. Global Dog Vaccines Sales Market Share by Type (2017-2028)
Figure 35. Global Dog Vaccines Revenue Market Share by Type (2017-2028)
Figure 36. Global Dog Vaccines Price by Type (2017-2028) & (USD/Dose)
Figure 37. Global Dog Vaccines Sales Market Share by Application (2017-2028)
Figure 38. Global Dog Vaccines Revenue Market Share by Application (2017-2028)
Figure 39. Global Dog Vaccines Price by Application (2017-2028) & (USD/Dose)
Figure 40. North America Dog Vaccines Sales Market Share by Type (2017-2028)
Figure 41. North America Dog Vaccines Sales Market Share by Application (2017-2028)
Figure 42. North America Dog Vaccines Sales Market Share by Country (2017-2028)
Figure 43. North America Dog Vaccines Revenue Market Share by Country (2017-2028)
Figure 44. United States Dog Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Dog Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Dog Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Dog Vaccines Sales Market Share by Type (2017-2028)
Figure 48. Europe Dog Vaccines Sales Market Share by Application (2017-2028)
Figure 49. Europe Dog Vaccines Sales Market Share by Country (2017-2028)
Figure 50. Europe Dog Vaccines Revenue Market Share by Country (2017-2028)
Figure 51. Germany Dog Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Dog Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Dog Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Dog Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Dog Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Dog Vaccines Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Dog Vaccines Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Dog Vaccines Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Dog Vaccines Revenue Market Share by Region (2017-2028)
Figure 60. China Dog Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Dog Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Dog Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Dog Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Dog Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Dog Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Dog Vaccines Sales Market Share by Type (2017-2028)
Figure 67. South America Dog Vaccines Sales Market Share by Application (2017-2028)
Figure 68. South America Dog Vaccines Sales Market Share by Country (2017-2028)
Figure 69. South America Dog Vaccines Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Dog Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Dog Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Dog Vaccines Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Dog Vaccines Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Dog Vaccines Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Dog Vaccines Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Dog Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Dog Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Dog Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Dog Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Dog Vaccines in 2021
Figure 81. Manufacturing Process Analysis of Dog Vaccines
Figure 82. Dog Vaccines Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
